#cell therapy — Wednesday, July 29, 2026 (1 items)
| 0 | 💬 0 |
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.
(linkinghub.elsevier.com)
|
The Lancet 2026-07-29 | #muscular dystrophy #clinical trial #cell therapy #cardiomyopathy |